Status:
RECRUITING
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
Lead Sponsor:
University of California, Davis
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer....
Detailed Description
OBJECTIVES: * Examine the mutational status of the EGFR pathway in tumor and blood samples from patients with lung cancer. * Correlate the EGFR pathway mutations in these samples with clinical outcom...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Histologically or cytologically confirmed lung cancer
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- May have received prior EGFR inhibitors
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT00899405
Start Date
May 1 2005
End Date
December 1 2026
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Davis Cancer Center
Sacramento, California, United States, 95817